Screener
Summit Therapeutics SMMT Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
FAQ
- What is Summit Therapeutics's restricted cash?
- Summit Therapeutics (SMMT) reported restricted cash of $316K in Q1 2026.
- How has Summit Therapeutics's restricted cash changed year-over-year?
- Summit Therapeutics's restricted cash decreased by 0.6% year-over-year, from $318K to $316K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Summit Therapeutics's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude